Clinical trial
Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men
NCT00151684 · Rijnstate Hospital, Other · Completed
Key facts
| NCT number | NCT00151684 |
|---|---|
| Title | Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men |
| Official title | Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men: a Dose Response Study, Part II |
| Lead sponsor | Rijnstate Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity, Hyperinsulinism |
| Intervention type | Drug |
| Interventions | Diazoxide |
| Enrollment | 25 |
| Start date | Nov 1, 2004 |
| First posted | Sep 9, 2005 |
| Last update posted | Feb 29, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: